Talis Biomedical Corporation (TLIS) reports Q1 results

Talis Biomedical Corporation (NASDAQ: TLIS) reported Q1 results. Revenue for the quarter came in at $1.2 million versus the consensus estimate of $230 thousand.

For earnings history and earnings-related data on Talis Biomedical Corporation (TLIS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c